HealthStream, Inc. (NASDAQ:HSTM) to Issue Quarterly Dividend of $0.03

HealthStream, Inc. (NASDAQ:HSTM - Get Free Report) announced a quarterly dividend on Monday, October 21st, Zacks reports. Investors of record on Monday, November 4th will be paid a dividend of 0.028 per share by the technology company on Friday, November 15th. This represents a $0.11 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date is Monday, November 4th.

HealthStream has a dividend payout ratio of 17.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect HealthStream to earn $0.61 per share next year, which means the company should continue to be able to cover its $0.11 annual dividend with an expected future payout ratio of 18.0%.

HealthStream Price Performance

NASDAQ:HSTM traded down $1.44 during trading hours on Wednesday, reaching $28.63. 163,778 shares of the company were exchanged, compared to its average volume of 112,590. The company has a market capitalization of $870.29 million, a P/E ratio of 49.36, a P/E/G ratio of 4.25 and a beta of 0.36. HealthStream has a 1-year low of $22.84 and a 1-year high of $31.15. The business has a 50 day moving average of $28.68 and a 200 day moving average of $27.88.

HealthStream (NASDAQ:HSTM - Get Free Report) last issued its earnings results on Monday, October 21st. The technology company reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.13 by $0.06. The firm had revenue of $73.10 million for the quarter, compared to the consensus estimate of $73.53 million. HealthStream had a return on equity of 5.19% and a net margin of 6.26%. The company's revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.13 EPS. As a group, equities research analysts anticipate that HealthStream will post 0.56 earnings per share for the current fiscal year.

Insider Activity

In other news, SVP Kevin P. O'hara sold 3,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the transaction, the senior vice president now directly owns 9,527 shares in the company, valued at approximately $267,041.81. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Tate Deborah Taylor sold 1,400 shares of the firm's stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total transaction of $39,942.00. Following the completion of the transaction, the director now directly owns 22,326 shares of the company's stock, valued at $636,960.78. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Kevin P. O'hara sold 3,000 shares of the firm's stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the transaction, the senior vice president now directly owns 9,527 shares of the company's stock, valued at approximately $267,041.81. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 20.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

HSTM has been the topic of a number of research analyst reports. StockNews.com downgraded HealthStream from a "strong-buy" rating to a "buy" rating in a report on Wednesday, July 24th. Craig Hallum raised HealthStream to a "strong-buy" rating in a report on Thursday, October 17th. Barclays raised their target price on HealthStream from $32.00 to $34.00 and gave the company an "overweight" rating in a report on Wednesday. Finally, Canaccord Genuity Group raised their target price on HealthStream from $28.00 to $29.00 and gave the company a "hold" rating in a report on Wednesday. Two equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $31.50.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.